TuesdayMay 12, 2026 10:30 am

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Announces Exercised Warrants and Debentures; Positioned to Capitalize on the Current Precious Metals Market

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF)and may include paid advertising. CMX Gold & Silver Corp., an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, just announced that a total of 3,320,000 warrants were exercised for the purchase of 3,320,000 common shares at $0.10 a share. Debentures aggregating $190,000 of principal were also converted into 1,520,000 shares at a conversion price of $0.125 a share. 1,520,000 shares were exercised by the settlement of $152,000 of debt, with cash proceeds of $180,000 from the exercise of warrants for 1,800,000 shares applied to working…

Continue Reading

TuesdayMay 12, 2026 9:45 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Looks to Expand Rare Earth Portfolio with Northern Ontario Hopkins Project

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF)and may include paid advertising. The company has signed an option agreement to acquire a 100% interest in the Hopkins Rare Earths Project in northern Ontario. The property covers approximately 5,900 hectares within the Clay-Howells Alkalic Rock Complex, and a geological setting associated with rare earth element (“REE”) exploration, with planned exploration includes airborne geophysics, radiometric surveys, mapping, and geochemical sampling. Management says the acquisition strengthens Powermax’s growing North American REE portfolio alongside projects in British Columbia, Ontario, and Wyoming. Growing Western interest in domestic REE supply chains continues to…

Continue Reading

TuesdayMay 12, 2026 9:00 am

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Is ‘One to Watch’

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF)and may include a paid advertisement. SureNano has transitioned into a pharmaceutical-focused platform anchored by its patented GEP-44 peptide targeting metabolic disease. Preclinical data for GEP-44 demonstrates meaningful weight loss, improved glucose control, and a favorable tolerability profile relative to existing GLP-1 therapies. The company’s vertically integrated model combines therapeutic development with delivery technologies, supporting differentiation through potential non-injectable formats. SureNano is advancing GEP-44 through a defined regulatory pathway, including IND-enabling studies and planned clinical trials. The company provides exposure to the expanding GLP-1 and obesity treatment markets, which are…

Continue Reading

MondayMay 11, 2026 11:15 am

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Toward Clinical Stage with IND-Enabling Program for GLP GEP-44

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include a paid advertisement. SureNano Science initiated an FDA-aligned IND-enabling GLP toxicology and pharmacology program for lead candidate GEP-44, a multi-receptor peptide targeting obesity and type 2 diabetes, positioned within the growing GLP-1 therapeutic market as a minnow among giants. The studies will assess safety, dosing thresholds, and pharmacological effects across multiple species, GEP-44 preclinical results position it head-to-head with leaders such as Ozempic, Mounjaro, Wegovy. The program is expected to support a Phase I clinical trial in Australia, subject to regulatory submission and study outcomes. The…

Continue Reading

MondayMay 11, 2026 10:30 am

The Partnership Playbook: Oncotelic Therapeutics Inc. (OTLC) Advancing Its Pipeline Without Dilution

The GMP Bio joint venture contributed a $249 million increase to Oncotelic’s balance sheet through independent third-party valuation The company is leveraging a deep intellectual property portfolio, including more than 500 patent applications and 75 issued patents Oncotelic’s PDAOAI platform has integrated approximately 28 million scientific abstracts and is advancing toward commercial deployment with robotics integration In clinical-stage biotechnology, the central challenge is rarely scientific discovery. It is capital. Advancing multiple therapeutic candidates through preclinical work, clinical trials, and regulatory approval requires sustained funding, and traditional financing routes often come at the cost of dilution or loss of asset control.…

Continue Reading

MondayMay 11, 2026 9:45 am

Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) Enters Orbital Power Race as Space Economy Faces Energy Bottleneck

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising. Rising power demands from satellites, AI workloads, and space-based infrastructure are creating a new bottleneck in orbit Planet Ventures recent investment in Mantis Space highlights Planet’s strategy of backing foundational technologies in high-growth sectors The company recently announced the appointment of Dr. Bora to its leadership team, bringing experience in science, technology, and innovation Planet Ventures (CSE: PXI) (OTC: PNXPF) is strategically positioning itself at the forefront of a critical shift in the global space economy: the race to build scalable energy infrastructure in orbit.…

Continue Reading

MondayMay 11, 2026 9:00 am

Greenland Energy Company (NASDAQ: GLND) Targets Frontier Energy Opportunity as Global Supply Pressures Intensify

Global energy markets are looking beyond traditional oil basins as reserve depletion and supply pressures intensify. Greenland Energy Company is focused on Greenland’s Jameson Land Basin, a high-potential and largely underexplored hydrocarbon region. The company aims to unlock frontier-scale energy resources that support long-term supply security and strategic diversification. Greenland Energy (NASDAQ: GLND) is positioning itself within a shifting global energy landscape, as policymakers and industry leaders increasingly look beyond traditional oil-producing regions in search of new, scalable hydrocarbon resources. Years of underinvestment in upstream development, combined with reserve depletion in mature basins and rising geopolitical instability, are driving renewed…

Continue Reading

FridayMay 08, 2026 11:15 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Expands Gold Asset Portfolio in Abitibi Supporting Mine-to-Mill Platform

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. Canadian near-term gold producer LaFleur Minerals is increasing its holdings within the prolific Abitibi Greenstone Belt in Quebec through the value-accretive acquisition of the 78.5-square-kilometer McKenzie East Gold Project LaFleur has already been conducting an exploratory drilling operation at its nearby Swanson Gold Project, which has been shown to have broad, continuous zones of gold mineralization Swanson, and now McKenzie East, have the potential to serve as sources of feedstock for LaFleur’s Beacon Gold Mill, which the company expects to restart later this quarter…

Continue Reading

FridayMay 08, 2026 10:30 am

American Fusion(TM) Inc. (AMFN) Expands into Government Procurement While Advancing Fusion Energy Development

American Fusion(TM) launched a Government Procurement Services segment alongside its fusion energy development business. The company announced an initial transaction tied to a Canadian Department of National Defence procurement requirement. The approximately $58,000 purchase order involves specialized RF measurement equipment supplied through Canadian contractor Effective Acceleration Ventures Ltd. Management views the procurement segment as a way to build institutional and defense-sector relationships while its fusion platform continues development. Through subsidiary Kepler Fusion Technologies, the company continues to develop the Texatron(TM) fusion platform for modular energy applications. American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is expanding beyond…

Continue Reading

FridayMay 08, 2026 9:45 am

ESGold Corp.’s (CSE: ESAU) (OTCQB: ESAUF) CEO, Gordon Robb, Acknowledges 2026 as a ‘Very Big Year’ for the Company, with Ambitious Plan for Upcoming Milestones

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, sees 2026 as an exciting year for its Montauban Gold-Silver Project in Quebec While appearing on The MiningNewsWire Podcast, Gordon Robb, ESGold’s CEO, noted that the company has now laid down the needed foundations, and has a number of important milestones coming up The foundations include securing all equipment and making significant progress on its 20,000 sq. ft. processing facility, which followed a C$7.2 million raise from the sale…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered